Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 4
1964 1
1969 1
1973 1
1979 1
1981 2
1982 1
1983 1
1985 5
1986 1
1987 2
1989 5
1990 1
1991 1
1993 1
1994 3
1995 1
1996 1
1997 1
1998 3
1999 1
2001 2
2004 2
2006 4
2008 2
2009 4
2010 7
2011 5
2012 4
2013 2
2014 3
2015 2
2016 5
2017 3
2018 5
2019 7
2020 9
2021 14
2022 8
2023 2
2024 6
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial.
Hungria V, Robak P, Hus M, Zherebtsova V, Ward C, Ho PJ, Hájek R, Kim K, Grosicki S, Sia H, Bryant A, Pitombeira de Lacerda M, Martinez GA, Sureda Balarí A, Sandhu I, Cerchione C, Ganly P, Dimopoulos MA, Fu C, Garg M, Abdallah AO, Gatt ME, Oriol Rocafiguera A, Cavo M, Rifkin R, Fujisaki T, Mielnik M, Ficek J, Mantero A, Pirooz N, Varghese S, Lee J, McKeown A, Rogers R, Baig H, Eccersley L, Roy-Ghanta S, Mukhopadhyay P, Nielsen J, Opalinska J, Mateos MV; DREAMM-7 study investigators. Hungria V, et al. Among authors: martinez ga. Lancet Oncol. 2025 Aug;26(8):1067-1080. doi: 10.1016/S1470-2045(25)00330-4. Epub 2025 Jul 15. Lancet Oncol. 2025. PMID: 40680754 Clinical Trial.
The Role of Glycosyltransferases in Colorectal Cancer.
Fernández-Ponce C, Geribaldi-Doldán N, Sánchez-Gomar I, Quiroz RN, Ibarra LA, Escorcia LG, Fernández-Cisnal R, Martinez GA, García-Cózar F, Quiroz EN. Fernández-Ponce C, et al. Among authors: martinez ga. Int J Mol Sci. 2021 May 30;22(11):5822. doi: 10.3390/ijms22115822. Int J Mol Sci. 2021. PMID: 34070747 Free PMC article. Review.
Amyloid Cardiomyopathy: Establishing a Patient Referral Center in Brazil.
Szor RS, Alencar A, Bueno BVK, Cafezeiro CRF, Alves LBO, Hajjar LA, Martinez GA, Rocha V, Fernandes F. Szor RS, et al. Among authors: martinez ga. JACC CardioOncol. 2021 Oct 19;3(4):606-610. doi: 10.1016/j.jaccao.2021.06.001. eCollection 2021 Oct. JACC CardioOncol. 2021. PMID: 34729536 Free PMC article. No abstract available.
Scoping Review of Textbooks for Medical Spanish Education.
Shin TM, Hardin K, Johnston D, Rajadhyaksha E, Diamond LC, Chang R, Martínez GA, Ortega P. Shin TM, et al. Among authors: martinez ga. Med Sci Educ. 2021 Jun 2;31(4):1519-1527. doi: 10.1007/s40670-021-01333-8. eCollection 2021 Aug. Med Sci Educ. 2021. PMID: 34457990 Free PMC article.
Modification of Belantamab Mafodotin Dosing to Balance Efficacy and Tolerability in the DREAMM-7 and DREAMM-8 Trials.
Mateos MV, Trudel S, Quach H, Robak P, Beksac M, Pour L, Hus M, Kim K, Zherebtsova V, Delimpasi S, Jelínek T, Ward C, Ho PJ, Vorobyev VI, Lacerda MP, Martinez GA, Spicka I, Radocha J, Cavo M, Cerchione C, Fu C, Suzuki K, Rogers R, Phillips-Jones A, Wang Z, Baig H, Wilkes J, Zhou XL, Lewis E, Eccersley L, Sule N, Paka P, Opalinska JB, Mukhopadhyay P, Hungria VTM, Dimopoulos MA. Mateos MV, et al. Among authors: martinez ga. Blood Adv. 2025 Aug 5:bloodadvances.2025016949. doi: 10.1182/bloodadvances.2025016949. Online ahead of print. Blood Adv. 2025. PMID: 40763276
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial.
Hungria V, Hus M, Fu C, Zherebtsova V, Ward C, Ho PJ, Mikulski D, Muronova L, Cerchione C, Loubert A, Bunod L, M'Hari M, Pirooz N, Rogers R, Lin CP, Roy-Ghanta S, Opalinska JB, Purser M, McKeown A, McNamara S, Baig H, Eccersley L, Pompilus F, Mateos MV; DREAMM-7 trial study group. Hungria V, et al. Lancet Haematol. 2025 Aug;12(8):e599-e610. doi: 10.1016/S2352-3026(25)00163-2. Epub 2025 Jul 15. Lancet Haematol. 2025. PMID: 40680752 Clinical Trial.
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA.
Gargallo-Puyuelo CJ, Ricart E, Iglesias E, de Francisco R, Gisbert JP, Taxonera C, Mañosa M, Aguas Peris M, Navarrete-Muñoz EM, Sanahuja A, Guardiola J, Mesonero F, Rivero Tirado M, Barrio J, Vera Mendoza I, de Castro Parga L, García-Planella E, Calvet X, Martín Arranz MD, García S, Sicilia B, Carpio D, Domenech E, Gomollón F; ENEIDA registry of GETECCU. Gargallo-Puyuelo CJ, et al. Clin Gastroenterol Hepatol. 2024 Nov;22(11):2280-2290. doi: 10.1016/j.cgh.2024.05.013. Epub 2024 May 22. Clin Gastroenterol Hepatol. 2024. PMID: 38782172
123 results